Cargando…

Absence of tissue transglutaminase reduces amyloid‐beta pathology in APP23 mice

AIMS: Alzheimer's disease (AD) is characterised by amyloid‐beta (Aβ) aggregates in the brain. Targeting Aβ aggregates is a major approach for AD therapies, although attempts have had little to no success so far. A novel treatment option is to focus on blocking the actual formation of Aβ multime...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilhelmus, Micha M. M., Chouchane, Osoul, Loos, Maarten, Jongenelen, Cornelis A. M., Brevé, John J. P., Jonker, Allert, Bol, John G. J. M., Smit, August B., Drukarch, Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304226/ https://www.ncbi.nlm.nih.gov/pubmed/35141929 http://dx.doi.org/10.1111/nan.12796

Ejemplares similares

The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer’s Disease
por: Wilhelmus, Micha M. M., et al.
Publicado: (2022)

Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis
por: Chrobok, Navina L., et al.
Publicado: (2018)

Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis
por: Chrobok, Navina L., et al.
Publicado: (2018)

Astrocyte-Derived Tissue Transglutaminase Interacts with Fibronectin: A Role in Astrocyte Adhesion and Migration?
por: van Strien, Miriam E., et al.
Publicado: (2011)

Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer’s disease mouse models
por: Wilhelmus, Micha M. M., et al.
Publicado: (2016)

Tissue Transglutaminase Appears in Monocytes and Macrophages but Not in Lymphocytes in White Matter Multiple Sclerosis Lesions
por: Chrobok, Navina L, et al.
Publicado: (2019)

Differential Expression of Tissue Transglutaminase Splice Variants in Peripheral Blood Mononuclear Cells of Primary Progressive Multiple Sclerosis Patients
por: Sestito, Claudia, et al.
Publicado: (2018)

In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model
por: van der Wildt, Berend, et al.
Publicado: (2018)

Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis
por: Sestito, Claudia, et al.
Publicado: (2021)

Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?
por: Chrobok, Navina L., et al.
Publicado: (2016)

Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures
por: Espitia Pinzón, Nathaly, et al.
Publicado: (2017)

Monocyte behaviour and tissue transglutaminase expression during experimental autoimmune encephalomyelitis in transgenic CX3CR1(gfp/gfp) mice
por: Chrobok, Navina L., et al.
Publicado: (2016)

Tissue Transglutaminase Promotes Early Differentiation of Oligodendrocyte Progenitor Cells
por: Espitia Pinzon, Nathaly, et al.
Publicado: (2019)

Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination
por: Espitia Pinzon, Nathaly, et al.
Publicado: (2017)

Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?
por: Sestito, Claudia, et al.
Publicado: (2017)

Thinking about the action potential: the nerve signal as a window to the physical principles guiding neuronal excitability
por: Drukarch, Benjamin, et al.
Publicado: (2023)

Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter
por: Espitia Pinzon, Nathaly, et al.
Publicado: (2014)

Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression
por: Ruiz-Riquelme, Alejandro, et al.
Publicado: (2018)

Heat Shock Proteins and Amateur Chaperones in Amyloid-Beta Accumulation and Clearance in Alzheimer’s Disease
por: Wilhelmus, Micha M. M., et al.
Publicado: (2007)

Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography
por: van der Wildt, Berend, et al.
Publicado: (2016)

Measuring discrimination- and reversal learning in mouse models within 4 days and without prior food deprivation
por: Remmelink, Esther, et al.
Publicado: (2016)

AHCODA-DB: a data repository with web-based mining tools for the analysis of automated high-content mouse phenomics data
por: Koopmans, Bastijn, et al.
Publicado: (2017)

Axonal degeneration in the anterior insular cortex is associated with Alzheimer’s co-pathology in Parkinson’s disease and dementia with Lewy bodies
por: Fathy, Yasmine Y., et al.
Publicado: (2022)

Biotechnological Applications of Transglutaminases
por: Rachel, Natalie M., et al.
Publicado: (2013)

Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo
por: Jeitner, Thomas M., et al.
Publicado: (2018)

A one-week 5-choice serial reaction time task to measure impulsivity and attention in adult and adolescent mice
por: Remmelink, Esther, et al.
Publicado: (2017)

Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients
por: Prins, Marloes, et al.
Publicado: (2014)

Customization in mobile health apps: explaining effects on physical activity intentions by the need for autonomy
por: Bol, Nadine, et al.
Publicado: (2019)

Transglutaminases Are Active in Perivascular Adipose Tissue
por: Orr, Alexis N., et al.
Publicado: (2021)

Enhanced alcohol self-administration and reinstatement in a highly impulsive, inattentive recombinant inbred mouse strain
por: Loos, Maarten, et al.
Publicado: (2013)

Genetic Variation in CNS Myelination and Functional Brain Connectivity in Recombinant Inbred Mice
por: Goudriaan, Andrea, et al.
Publicado: (2020)

Increased Osteoclastogenesis in Absence of TG2 Is Reversed by Transglutaminase Inhibition—Evidence for the Role for TG1 in Osteoclast Formation
por: Ebrahimi Samani, Sahar, et al.
Publicado: (2023)

Activation and Inhibition of Transglutaminase 2 in Mice
por: Dafik, Laila, et al.
Publicado: (2012)

Transglutaminases in Monocytes and Macrophages
por: Sun, Huifang, et al.
Publicado: (2018)

Transglutaminase in neurological disease
por: Hoffner, Guylaine, et al.
Publicado: (2017)

Transglutaminase in Foods and Biotechnology
por: Vasić, Katja, et al.
Publicado: (2023)

Tissue Transglutaminase but Not Microbial Transglutaminase Is Inhibited by Exogenous Oxidative Substances in Celiac Disease
por: Stricker, Sebastian, et al.
Publicado: (2022)

Amyloid, APP, and Electrical Activity of the Brain
por: Hefter, Dimitri, et al.
Publicado: (2019)

Neurophysiological alterations in mice and humans carrying mutations in APP and PSEN1 genes
por: van Heusden, Fran C., et al.
Publicado: (2023)

Brain region-specific gene expression profiles in freshly isolated rat microglia
por: Doorn, Karlijn J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qn4darlirbunrlfu814j6tbrm1